nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2A6—Progesterone—uterine cancer	0.255	0.372	CbGbCtD
Formoterol—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.132	0.193	CbGbCtD
Formoterol—CYP2C19—Progesterone—uterine cancer	0.105	0.154	CbGbCtD
Formoterol—CYP2C9—Progesterone—uterine cancer	0.0877	0.128	CbGbCtD
Formoterol—CYP2D6—Progesterone—uterine cancer	0.0802	0.117	CbGbCtD
Formoterol—CYP2D6—Doxorubicin—uterine cancer	0.0245	0.0357	CbGbCtD
Formoterol—Dermatitis contact—Doxorubicin—uterine cancer	0.000487	0.00155	CcSEcCtD
Formoterol—Hyperkalaemia—Doxorubicin—uterine cancer	0.000484	0.00154	CcSEcCtD
Formoterol—Discomfort—Dactinomycin—uterine cancer	0.000483	0.00153	CcSEcCtD
Formoterol—Bladder pain—Epirubicin—uterine cancer	0.000482	0.00153	CcSEcCtD
Formoterol—Neoplasm—Epirubicin—uterine cancer	0.000482	0.00153	CcSEcCtD
Formoterol—Cystitis noninfective—Doxorubicin—uterine cancer	0.000481	0.00153	CcSEcCtD
Formoterol—Melaena—Doxorubicin—uterine cancer	0.000481	0.00153	CcSEcCtD
Formoterol—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000477	0.00152	CcSEcCtD
Formoterol—Cystitis—Doxorubicin—uterine cancer	0.000476	0.00151	CcSEcCtD
Formoterol—Asthenia—Progesterone—uterine cancer	0.000476	0.00151	CcSEcCtD
Formoterol—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000475	0.00151	CcSEcCtD
Formoterol—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000475	0.00151	CcSEcCtD
Formoterol—Urinary tract disorder—Etoposide—uterine cancer	0.000471	0.0015	CcSEcCtD
Formoterol—Candida infection—Doxorubicin—uterine cancer	0.000471	0.0015	CcSEcCtD
Formoterol—Pruritus—Progesterone—uterine cancer	0.000469	0.00149	CcSEcCtD
Formoterol—Oedema—Dactinomycin—uterine cancer	0.000468	0.00149	CcSEcCtD
Formoterol—Urethral disorder—Etoposide—uterine cancer	0.000468	0.00149	CcSEcCtD
Formoterol—Infection—Dactinomycin—uterine cancer	0.000465	0.00148	CcSEcCtD
Formoterol—Abnormal vision—Epirubicin—uterine cancer	0.000465	0.00148	CcSEcCtD
Formoterol—Diarrhoea—Progesterone—uterine cancer	0.000454	0.00144	CcSEcCtD
Formoterol—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000453	0.00144	CcSEcCtD
Formoterol—Neoplasm—Doxorubicin—uterine cancer	0.000446	0.00142	CcSEcCtD
Formoterol—Bladder pain—Doxorubicin—uterine cancer	0.000446	0.00142	CcSEcCtD
Formoterol—Cardiac disorder—Etoposide—uterine cancer	0.000443	0.00141	CcSEcCtD
Formoterol—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000443	0.00141	CcSEcCtD
Formoterol—Dizziness—Progesterone—uterine cancer	0.000438	0.00139	CcSEcCtD
Formoterol—Immune system disorder—Etoposide—uterine cancer	0.000431	0.00137	CcSEcCtD
Formoterol—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000431	0.00137	CcSEcCtD
Formoterol—Mediastinal disorder—Etoposide—uterine cancer	0.00043	0.00137	CcSEcCtD
Formoterol—Abnormal vision—Doxorubicin—uterine cancer	0.00043	0.00137	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000427	0.00136	CcSEcCtD
Formoterol—Cardiac failure congestive—Epirubicin—uterine cancer	0.000426	0.00136	CcSEcCtD
Formoterol—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000425	0.00135	CcSEcCtD
Formoterol—Vomiting—Progesterone—uterine cancer	0.000421	0.00134	CcSEcCtD
Formoterol—Rash—Progesterone—uterine cancer	0.000418	0.00133	CcSEcCtD
Formoterol—Dermatitis—Progesterone—uterine cancer	0.000418	0.00133	CcSEcCtD
Formoterol—Headache—Progesterone—uterine cancer	0.000415	0.00132	CcSEcCtD
Formoterol—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000411	0.00131	CcSEcCtD
Formoterol—Dysgeusia—Etoposide—uterine cancer	0.000407	0.00129	CcSEcCtD
Formoterol—Fatigue—Dactinomycin—uterine cancer	0.000404	0.00128	CcSEcCtD
Formoterol—Back pain—Etoposide—uterine cancer	0.000402	0.00128	CcSEcCtD
Formoterol—Pain—Dactinomycin—uterine cancer	0.000401	0.00127	CcSEcCtD
Formoterol—Muscle spasms—Etoposide—uterine cancer	0.000399	0.00127	CcSEcCtD
Formoterol—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000397	0.00126	CcSEcCtD
Formoterol—Hypoglycaemia—Epirubicin—uterine cancer	0.000396	0.00126	CcSEcCtD
Formoterol—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000395	0.00125	CcSEcCtD
Formoterol—Nausea—Progesterone—uterine cancer	0.000394	0.00125	CcSEcCtD
Formoterol—Feeling abnormal—Dactinomycin—uterine cancer	0.000386	0.00123	CcSEcCtD
Formoterol—Ill-defined disorder—Etoposide—uterine cancer	0.000385	0.00123	CcSEcCtD
Formoterol—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000383	0.00122	CcSEcCtD
Formoterol—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000382	0.00121	CcSEcCtD
Formoterol—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000379	0.0012	CcSEcCtD
Formoterol—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.0012	CcSEcCtD
Formoterol—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000376	0.0012	CcSEcCtD
Formoterol—Malaise—Etoposide—uterine cancer	0.000375	0.00119	CcSEcCtD
Formoterol—Abdominal pain—Dactinomycin—uterine cancer	0.00037	0.00118	CcSEcCtD
Formoterol—Body temperature increased—Dactinomycin—uterine cancer	0.00037	0.00118	CcSEcCtD
Formoterol—Hypoglycaemia—Doxorubicin—uterine cancer	0.000367	0.00117	CcSEcCtD
Formoterol—Cough—Etoposide—uterine cancer	0.000363	0.00115	CcSEcCtD
Formoterol—Dehydration—Epirubicin—uterine cancer	0.00036	0.00114	CcSEcCtD
Formoterol—Hypertension—Etoposide—uterine cancer	0.000359	0.00114	CcSEcCtD
Formoterol—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000357	0.00113	CcSEcCtD
Formoterol—Dry skin—Epirubicin—uterine cancer	0.000354	0.00113	CcSEcCtD
Formoterol—Chest pain—Etoposide—uterine cancer	0.000354	0.00112	CcSEcCtD
Formoterol—Hypokalaemia—Epirubicin—uterine cancer	0.000352	0.00112	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000351	0.00112	CcSEcCtD
Formoterol—Discomfort—Etoposide—uterine cancer	0.000349	0.00111	CcSEcCtD
Formoterol—Nasopharyngitis—Epirubicin—uterine cancer	0.000346	0.0011	CcSEcCtD
Formoterol—Hypersensitivity—Dactinomycin—uterine cancer	0.000345	0.0011	CcSEcCtD
Formoterol—Gastritis—Epirubicin—uterine cancer	0.000342	0.00109	CcSEcCtD
Formoterol—Anaphylactic shock—Etoposide—uterine cancer	0.000339	0.00108	CcSEcCtD
Formoterol—Infection—Etoposide—uterine cancer	0.000337	0.00107	CcSEcCtD
Formoterol—Asthenia—Dactinomycin—uterine cancer	0.000336	0.00107	CcSEcCtD
Formoterol—Influenza—Epirubicin—uterine cancer	0.000334	0.00106	CcSEcCtD
Formoterol—Asthma—Epirubicin—uterine cancer	0.000334	0.00106	CcSEcCtD
Formoterol—Dehydration—Doxorubicin—uterine cancer	0.000333	0.00106	CcSEcCtD
Formoterol—Tachycardia—Etoposide—uterine cancer	0.000331	0.00105	CcSEcCtD
Formoterol—Skin disorder—Etoposide—uterine cancer	0.000329	0.00105	CcSEcCtD
Formoterol—Dry skin—Doxorubicin—uterine cancer	0.000328	0.00104	CcSEcCtD
Formoterol—Hypokalaemia—Doxorubicin—uterine cancer	0.000326	0.00103	CcSEcCtD
Formoterol—Angina pectoris—Epirubicin—uterine cancer	0.000326	0.00103	CcSEcCtD
Formoterol—Bronchitis—Epirubicin—uterine cancer	0.000321	0.00102	CcSEcCtD
Formoterol—Diarrhoea—Dactinomycin—uterine cancer	0.000321	0.00102	CcSEcCtD
Formoterol—Nasopharyngitis—Doxorubicin—uterine cancer	0.00032	0.00102	CcSEcCtD
Formoterol—Hypotension—Etoposide—uterine cancer	0.000317	0.00101	CcSEcCtD
Formoterol—Gastritis—Doxorubicin—uterine cancer	0.000317	0.00101	CcSEcCtD
Formoterol—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000311	0.000987	CcSEcCtD
Formoterol—Influenza—Doxorubicin—uterine cancer	0.000309	0.000983	CcSEcCtD
Formoterol—Asthma—Doxorubicin—uterine cancer	0.000309	0.000983	CcSEcCtD
Formoterol—Dyspnoea—Etoposide—uterine cancer	0.000302	0.000961	CcSEcCtD
Formoterol—Hyperglycaemia—Epirubicin—uterine cancer	0.000302	0.000958	CcSEcCtD
Formoterol—Somnolence—Etoposide—uterine cancer	0.000301	0.000958	CcSEcCtD
Formoterol—Angina pectoris—Doxorubicin—uterine cancer	0.000301	0.000957	CcSEcCtD
Formoterol—Vomiting—Dactinomycin—uterine cancer	0.000298	0.000947	CcSEcCtD
Formoterol—Bronchitis—Doxorubicin—uterine cancer	0.000297	0.000945	CcSEcCtD
Formoterol—Rash—Dactinomycin—uterine cancer	0.000295	0.000939	CcSEcCtD
Formoterol—Gastrointestinal disorder—Etoposide—uterine cancer	0.000293	0.00093	CcSEcCtD
Formoterol—Fatigue—Etoposide—uterine cancer	0.000292	0.000929	CcSEcCtD
Formoterol—Pain—Etoposide—uterine cancer	0.00029	0.000921	CcSEcCtD
Formoterol—Constipation—Etoposide—uterine cancer	0.00029	0.000921	CcSEcCtD
Formoterol—Conjunctivitis—Epirubicin—uterine cancer	0.00029	0.000921	CcSEcCtD
Formoterol—Urinary tract infection—Epirubicin—uterine cancer	0.00029	0.000921	CcSEcCtD
Formoterol—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000287	0.000913	CcSEcCtD
Formoterol—Haematuria—Epirubicin—uterine cancer	0.000284	0.000903	CcSEcCtD
Formoterol—Sinusitis—Epirubicin—uterine cancer	0.00028	0.000889	CcSEcCtD
Formoterol—Feeling abnormal—Etoposide—uterine cancer	0.000279	0.000888	CcSEcCtD
Formoterol—Hyperglycaemia—Doxorubicin—uterine cancer	0.000279	0.000887	CcSEcCtD
Formoterol—Nausea—Dactinomycin—uterine cancer	0.000278	0.000884	CcSEcCtD
Formoterol—Gastrointestinal pain—Etoposide—uterine cancer	0.000277	0.000881	CcSEcCtD
Formoterol—Urticaria—Etoposide—uterine cancer	0.000269	0.000856	CcSEcCtD
Formoterol—Rhinitis—Epirubicin—uterine cancer	0.000268	0.000852	CcSEcCtD
Formoterol—Body temperature increased—Etoposide—uterine cancer	0.000268	0.000852	CcSEcCtD
Formoterol—Abdominal pain—Etoposide—uterine cancer	0.000268	0.000852	CcSEcCtD
Formoterol—Conjunctivitis—Doxorubicin—uterine cancer	0.000268	0.000852	CcSEcCtD
Formoterol—Urinary tract infection—Doxorubicin—uterine cancer	0.000268	0.000852	CcSEcCtD
Formoterol—Pharyngitis—Epirubicin—uterine cancer	0.000266	0.000844	CcSEcCtD
Formoterol—Urinary tract disorder—Epirubicin—uterine cancer	0.000264	0.00084	CcSEcCtD
Formoterol—Oedema peripheral—Epirubicin—uterine cancer	0.000264	0.000838	CcSEcCtD
Formoterol—Haematuria—Doxorubicin—uterine cancer	0.000263	0.000836	CcSEcCtD
Formoterol—Connective tissue disorder—Epirubicin—uterine cancer	0.000263	0.000835	CcSEcCtD
Formoterol—Urethral disorder—Epirubicin—uterine cancer	0.000262	0.000833	CcSEcCtD
Formoterol—Sinusitis—Doxorubicin—uterine cancer	0.000259	0.000822	CcSEcCtD
Formoterol—Visual impairment—Epirubicin—uterine cancer	0.000258	0.000819	CcSEcCtD
Formoterol—Hypersensitivity—Etoposide—uterine cancer	0.00025	0.000794	CcSEcCtD
Formoterol—Cardiac disorder—Epirubicin—uterine cancer	0.000248	0.000789	CcSEcCtD
Formoterol—Rhinitis—Doxorubicin—uterine cancer	0.000248	0.000789	CcSEcCtD
Formoterol—Pharyngitis—Doxorubicin—uterine cancer	0.000246	0.000781	CcSEcCtD
Formoterol—Urinary tract disorder—Doxorubicin—uterine cancer	0.000244	0.000777	CcSEcCtD
Formoterol—Oedema peripheral—Doxorubicin—uterine cancer	0.000244	0.000775	CcSEcCtD
Formoterol—Asthenia—Etoposide—uterine cancer	0.000243	0.000773	CcSEcCtD
Formoterol—Connective tissue disorder—Doxorubicin—uterine cancer	0.000243	0.000773	CcSEcCtD
Formoterol—Urethral disorder—Doxorubicin—uterine cancer	0.000243	0.000771	CcSEcCtD
Formoterol—Immune system disorder—Epirubicin—uterine cancer	0.000242	0.000768	CcSEcCtD
Formoterol—Mediastinal disorder—Epirubicin—uterine cancer	0.000241	0.000766	CcSEcCtD
Formoterol—Pruritus—Etoposide—uterine cancer	0.00024	0.000762	CcSEcCtD
Formoterol—Arrhythmia—Epirubicin—uterine cancer	0.000239	0.000759	CcSEcCtD
Formoterol—Visual impairment—Doxorubicin—uterine cancer	0.000239	0.000758	CcSEcCtD
Formoterol—Mental disorder—Epirubicin—uterine cancer	0.000234	0.000745	CcSEcCtD
Formoterol—Malnutrition—Epirubicin—uterine cancer	0.000233	0.00074	CcSEcCtD
Formoterol—Diarrhoea—Etoposide—uterine cancer	0.000232	0.000737	CcSEcCtD
Formoterol—Cardiac disorder—Doxorubicin—uterine cancer	0.00023	0.00073	CcSEcCtD
Formoterol—Tension—Epirubicin—uterine cancer	0.000229	0.000726	CcSEcCtD
Formoterol—Dysgeusia—Epirubicin—uterine cancer	0.000228	0.000725	CcSEcCtD
Formoterol—Nervousness—Epirubicin—uterine cancer	0.000226	0.000719	CcSEcCtD
Formoterol—Back pain—Epirubicin—uterine cancer	0.000225	0.000716	CcSEcCtD
Formoterol—Dizziness—Etoposide—uterine cancer	0.000224	0.000713	CcSEcCtD
Formoterol—Muscle spasms—Epirubicin—uterine cancer	0.000224	0.000712	CcSEcCtD
Formoterol—Immune system disorder—Doxorubicin—uterine cancer	0.000224	0.000711	CcSEcCtD
Formoterol—Mediastinal disorder—Doxorubicin—uterine cancer	0.000223	0.000709	CcSEcCtD
Formoterol—Arrhythmia—Doxorubicin—uterine cancer	0.000221	0.000703	CcSEcCtD
Formoterol—Mental disorder—Doxorubicin—uterine cancer	0.000217	0.000689	CcSEcCtD
Formoterol—Ill-defined disorder—Epirubicin—uterine cancer	0.000216	0.000687	CcSEcCtD
Formoterol—Vomiting—Etoposide—uterine cancer	0.000216	0.000685	CcSEcCtD
Formoterol—Malnutrition—Doxorubicin—uterine cancer	0.000215	0.000685	CcSEcCtD
Formoterol—Agitation—Epirubicin—uterine cancer	0.000214	0.00068	CcSEcCtD
Formoterol—Rash—Etoposide—uterine cancer	0.000214	0.000679	CcSEcCtD
Formoterol—Dermatitis—Etoposide—uterine cancer	0.000214	0.000679	CcSEcCtD
Formoterol—Headache—Etoposide—uterine cancer	0.000212	0.000675	CcSEcCtD
Formoterol—Tension—Doxorubicin—uterine cancer	0.000211	0.000672	CcSEcCtD
Formoterol—Dysgeusia—Doxorubicin—uterine cancer	0.000211	0.000671	CcSEcCtD
Formoterol—Malaise—Epirubicin—uterine cancer	0.00021	0.000667	CcSEcCtD
Formoterol—Nervousness—Doxorubicin—uterine cancer	0.000209	0.000665	CcSEcCtD
Formoterol—Back pain—Doxorubicin—uterine cancer	0.000208	0.000662	CcSEcCtD
Formoterol—Muscle spasms—Doxorubicin—uterine cancer	0.000207	0.000658	CcSEcCtD
Formoterol—Palpitations—Epirubicin—uterine cancer	0.000206	0.000654	CcSEcCtD
Formoterol—Cough—Epirubicin—uterine cancer	0.000203	0.000646	CcSEcCtD
Formoterol—Nausea—Etoposide—uterine cancer	0.000201	0.00064	CcSEcCtD
Formoterol—Hypertension—Epirubicin—uterine cancer	0.000201	0.000639	CcSEcCtD
Formoterol—Ill-defined disorder—Doxorubicin—uterine cancer	0.0002	0.000635	CcSEcCtD
Formoterol—Arthralgia—Epirubicin—uterine cancer	0.000198	0.00063	CcSEcCtD
Formoterol—Chest pain—Epirubicin—uterine cancer	0.000198	0.00063	CcSEcCtD
Formoterol—Myalgia—Epirubicin—uterine cancer	0.000198	0.00063	CcSEcCtD
Formoterol—Agitation—Doxorubicin—uterine cancer	0.000198	0.000629	CcSEcCtD
Formoterol—Anxiety—Epirubicin—uterine cancer	0.000198	0.000628	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000197	0.000626	CcSEcCtD
Formoterol—Discomfort—Epirubicin—uterine cancer	0.000196	0.000623	CcSEcCtD
Formoterol—Malaise—Doxorubicin—uterine cancer	0.000194	0.000618	CcSEcCtD
Formoterol—Dry mouth—Epirubicin—uterine cancer	0.000194	0.000616	CcSEcCtD
Formoterol—Palpitations—Doxorubicin—uterine cancer	0.00019	0.000605	CcSEcCtD
Formoterol—Oedema—Epirubicin—uterine cancer	0.00019	0.000604	CcSEcCtD
Formoterol—Anaphylactic shock—Epirubicin—uterine cancer	0.00019	0.000604	CcSEcCtD
Formoterol—Infection—Epirubicin—uterine cancer	0.000189	0.0006	CcSEcCtD
Formoterol—Cough—Doxorubicin—uterine cancer	0.000188	0.000598	CcSEcCtD
Formoterol—Nervous system disorder—Epirubicin—uterine cancer	0.000186	0.000592	CcSEcCtD
Formoterol—Hypertension—Doxorubicin—uterine cancer	0.000186	0.000591	CcSEcCtD
Formoterol—Tachycardia—Epirubicin—uterine cancer	0.000186	0.00059	CcSEcCtD
Formoterol—Skin disorder—Epirubicin—uterine cancer	0.000185	0.000587	CcSEcCtD
Formoterol—Arthralgia—Doxorubicin—uterine cancer	0.000183	0.000583	CcSEcCtD
Formoterol—Myalgia—Doxorubicin—uterine cancer	0.000183	0.000583	CcSEcCtD
Formoterol—Chest pain—Doxorubicin—uterine cancer	0.000183	0.000583	CcSEcCtD
Formoterol—Anxiety—Doxorubicin—uterine cancer	0.000183	0.000581	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000182	0.000579	CcSEcCtD
Formoterol—Discomfort—Doxorubicin—uterine cancer	0.000181	0.000576	CcSEcCtD
Formoterol—Dry mouth—Doxorubicin—uterine cancer	0.000179	0.00057	CcSEcCtD
Formoterol—Hypotension—Epirubicin—uterine cancer	0.000178	0.000564	CcSEcCtD
Formoterol—Anaphylactic shock—Doxorubicin—uterine cancer	0.000176	0.000559	CcSEcCtD
Formoterol—Oedema—Doxorubicin—uterine cancer	0.000176	0.000559	CcSEcCtD
Formoterol—Infection—Doxorubicin—uterine cancer	0.000175	0.000555	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000173	0.00055	CcSEcCtD
Formoterol—Nervous system disorder—Doxorubicin—uterine cancer	0.000172	0.000548	CcSEcCtD
Formoterol—Insomnia—Epirubicin—uterine cancer	0.000172	0.000546	CcSEcCtD
Formoterol—Tachycardia—Doxorubicin—uterine cancer	0.000172	0.000545	CcSEcCtD
Formoterol—Skin disorder—Doxorubicin—uterine cancer	0.000171	0.000543	CcSEcCtD
Formoterol—Dyspnoea—Epirubicin—uterine cancer	0.000169	0.000538	CcSEcCtD
Formoterol—Somnolence—Epirubicin—uterine cancer	0.000169	0.000537	CcSEcCtD
Formoterol—Dyspepsia—Epirubicin—uterine cancer	0.000167	0.000532	CcSEcCtD
Formoterol—Hypotension—Doxorubicin—uterine cancer	0.000164	0.000522	CcSEcCtD
Formoterol—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000164	0.000521	CcSEcCtD
Formoterol—Fatigue—Epirubicin—uterine cancer	0.000164	0.000521	CcSEcCtD
Formoterol—Pain—Epirubicin—uterine cancer	0.000163	0.000517	CcSEcCtD
Formoterol—Constipation—Epirubicin—uterine cancer	0.000163	0.000517	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00016	0.000509	CcSEcCtD
Formoterol—Insomnia—Doxorubicin—uterine cancer	0.000159	0.000505	CcSEcCtD
Formoterol—Dyspnoea—Doxorubicin—uterine cancer	0.000157	0.000498	CcSEcCtD
Formoterol—Feeling abnormal—Epirubicin—uterine cancer	0.000157	0.000498	CcSEcCtD
Formoterol—Somnolence—Doxorubicin—uterine cancer	0.000156	0.000497	CcSEcCtD
Formoterol—Gastrointestinal pain—Epirubicin—uterine cancer	0.000155	0.000494	CcSEcCtD
Formoterol—Dyspepsia—Doxorubicin—uterine cancer	0.000155	0.000492	CcSEcCtD
Formoterol—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000152	0.000482	CcSEcCtD
Formoterol—Fatigue—Doxorubicin—uterine cancer	0.000152	0.000482	CcSEcCtD
Formoterol—Urticaria—Epirubicin—uterine cancer	0.000151	0.00048	CcSEcCtD
Formoterol—Pain—Doxorubicin—uterine cancer	0.00015	0.000478	CcSEcCtD
Formoterol—Constipation—Doxorubicin—uterine cancer	0.00015	0.000478	CcSEcCtD
Formoterol—Abdominal pain—Epirubicin—uterine cancer	0.00015	0.000477	CcSEcCtD
Formoterol—Body temperature increased—Epirubicin—uterine cancer	0.00015	0.000477	CcSEcCtD
Formoterol—Feeling abnormal—Doxorubicin—uterine cancer	0.000145	0.000461	CcSEcCtD
Formoterol—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000144	0.000457	CcSEcCtD
Formoterol—Hypersensitivity—Epirubicin—uterine cancer	0.00014	0.000445	CcSEcCtD
Formoterol—Urticaria—Doxorubicin—uterine cancer	0.00014	0.000444	CcSEcCtD
Formoterol—Body temperature increased—Doxorubicin—uterine cancer	0.000139	0.000442	CcSEcCtD
Formoterol—Abdominal pain—Doxorubicin—uterine cancer	0.000139	0.000442	CcSEcCtD
Formoterol—Asthenia—Epirubicin—uterine cancer	0.000136	0.000433	CcSEcCtD
Formoterol—Pruritus—Epirubicin—uterine cancer	0.000134	0.000427	CcSEcCtD
Formoterol—Diarrhoea—Epirubicin—uterine cancer	0.00013	0.000413	CcSEcCtD
Formoterol—Hypersensitivity—Doxorubicin—uterine cancer	0.00013	0.000412	CcSEcCtD
Formoterol—Asthenia—Doxorubicin—uterine cancer	0.000126	0.000401	CcSEcCtD
Formoterol—Dizziness—Epirubicin—uterine cancer	0.000126	0.000399	CcSEcCtD
Formoterol—Pruritus—Doxorubicin—uterine cancer	0.000124	0.000395	CcSEcCtD
Formoterol—Vomiting—Epirubicin—uterine cancer	0.000121	0.000384	CcSEcCtD
Formoterol—Diarrhoea—Doxorubicin—uterine cancer	0.00012	0.000382	CcSEcCtD
Formoterol—Rash—Epirubicin—uterine cancer	0.00012	0.000381	CcSEcCtD
Formoterol—Dermatitis—Epirubicin—uterine cancer	0.00012	0.00038	CcSEcCtD
Formoterol—Headache—Epirubicin—uterine cancer	0.000119	0.000378	CcSEcCtD
Formoterol—Dizziness—Doxorubicin—uterine cancer	0.000116	0.00037	CcSEcCtD
Formoterol—Nausea—Epirubicin—uterine cancer	0.000113	0.000359	CcSEcCtD
Formoterol—Vomiting—Doxorubicin—uterine cancer	0.000112	0.000355	CcSEcCtD
Formoterol—Rash—Doxorubicin—uterine cancer	0.000111	0.000352	CcSEcCtD
Formoterol—Dermatitis—Doxorubicin—uterine cancer	0.000111	0.000352	CcSEcCtD
Formoterol—Headache—Doxorubicin—uterine cancer	0.00011	0.00035	CcSEcCtD
Formoterol—Nausea—Doxorubicin—uterine cancer	0.000104	0.000332	CcSEcCtD
